Keros Therapeutics, Inc. (KROS)
10.78
-0.25
(-2.27%)
USD |
NASDAQ |
Aug 24, 16:00
10.79
+0.01
(+0.09%)
After-Hours: 20:00
Keros Therapeutics Total Liabilities (Quarterly) : 25.28M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 25.28M |
| March 31, 2026 | 26.66M |
| December 31, 2025 | 39.74M |
| September 30, 2025 | 39.20M |
| June 30, 2025 | 50.43M |
| March 31, 2025 | 55.69M |
| December 31, 2024 | 44.33M |
| September 30, 2024 | 46.44M |
| June 30, 2024 | 34.11M |
| March 31, 2024 | 31.87M |
| December 31, 2023 | 37.81M |
| September 30, 2023 | 30.40M |
| June 30, 2023 | 30.05M |
| March 31, 2023 | 29.45M |
| Date | Value |
|---|---|
| December 31, 2022 | 29.36M |
| September 30, 2022 | 11.52M |
| June 30, 2022 | 15.45M |
| March 31, 2022 | 11.65M |
| December 31, 2021 | 12.08M |
| September 30, 2021 | 11.48M |
| June 30, 2021 | 7.805M |
| March 31, 2021 | 9.358M |
| December 31, 2020 | 7.722M |
| September 30, 2020 | 7.488M |
| June 30, 2020 | 9.077M |
| March 31, 2020 | 85.46M |
| December 31, 2019 | 30.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Nurix Therapeutics, Inc. | 132.91M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 287.60M |
| Shareholders Equity (Quarterly) | 262.32M |
| Debt to Equity Ratio | 0.0599 |
| Current Ratio | 21.96 |
| Net Debt Paydown Yield | 0.25% |